Leadership

Our Scientists

In clinical proteomics, we invented the 1st proteomics-based platform to quantify mutant proteins from cancer patient body fluids in 2010, and we established the 1st clinical proteomics diagnostics platform for ovarian cancers with a zero false positive ratio, and most recently, we invented the 1st neoantigen quantification platform for highly personalized cancer therapeutics. In clinical genomics, we invented and patented the world’s only dual RNA probes for capture-based targeted sequencing for ultra-rare mutation calling (even compatible with tough and damaged clinical samples), and publications from our genomics scientists have been cited for over 8,000 times, numerous novel cancer driver genes and NGS-based early cancer diagnostic methods were reported by us. Now, we are doing something even more exciting … …

  • Qing Wang
  • Liang Zhao
  • Yuri Laguna Terai
  • Christopher Adewole
  • Parth Parikh
  • Hui Zhang
  • Ming Zhang
  • Hamza Umar
  • Raj Purohit
  • Stanley Wang

LET'S START DOING YOUR BIT FOR THE WORLD. JOIN US AS A VOLUNTEER.